Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C, Thiamine, and Steroids in Septic Shock
NCT03828929Phase 3Terminated
- Sponsor
- NewYork-Presbyterian Brooklyn Methodist Hospital
- Start
- Oct 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in septic shock comparing Vitamin C and Thiamine with Placebo (2 arms). Primary endpoint: All Cause in Hospital Mortality at 30 days. Started Oct 2019; status: terminated.
02
Drugs
ascorbic acidthiamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT03828929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03828929.